Pharmosa Biopharm Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Jul 2038
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jun 5, 2027The maintenance fee for Pharmaceutical composition for controlled release of treprostinil (US 11,833,125) comes due Jun 5, 2027. Unpaid by Dec 6, 2027, it lapses early.
- 1 fee due Oct 23, 2027The maintenance fee for Liposome Compositions Comprising Weak Acid Drugs and Uses Thereof (US 11,964,050) comes due Oct 23, 2027. Unpaid by Apr 24, 2028, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 22, 2026
- Sep 29 US 12,746,200 Pharmaceutical Composition for Controlled Release of Weak Acid Drugs and Uses Thereof
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 7 of 7
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,964,050 | Liposome Compositions Comprising Weak Acid Drugs and Uses Thereof In force · High confidence | In force | High confidence | |
| US 12,064,406 | Pharmaceutical Composition of a Weak Acid Drug and Methods of Administration In force · High confidence | In force | High confidence | |
| US 12,220,483 | Liposome Compositions Comprising Weak Acid Drugs and Uses Thereof In force · High confidence | In force | High confidence | |
| US 12,551,437 | Liposome Compositions Comprising Weak Acid Drugs and Uses Thereof In force · High confidence | In force | High confidence | |
| US 12,746,200 | Pharmaceutical Composition for Controlled Release of Weak Acid Drugs and Uses Thereof In force · High confidence | In force | High confidence | |
| US 11,229,616 | Pharmaceutical composition for controlled release of treprostinil In force · USPTO record | In force | USPTO record | |
| US 11,833,125 | Pharmaceutical composition for controlled release of treprostinil In force · USPTO record | In force | USPTO record |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending · 1 abandoned